# STEGLATRO

NDC: 0006-5364
Generic name: ertugliflozin
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20171219

FDA application: NDA209803

## Active ingredients

- ERTUGLIFLOZIN PIDOLATE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-5364"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-5364
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6f3e718-bb99-48f1-ab94-b9f0af05fed6